Abstract:Key PointsMucosal barrier function consists of the combined effects of multiple extracellular and cellular processes that may be disrupted globally or in a targeted manner by physiological and pathophysiological stimuli. In the presence of an intact epithelium, mucosal permeability is primarily determined by tight junction barrier function.Intestinal epithelial cells mediate interactions between the mucosal immune system and luminal materials. The mechanisms by which these epithelia regulate and, conversely, are regulated by the immune system are therefore of crucial importance to mucosal homeostasis and disease.In vitro and in vivo studies have indicated that cytokines, including tumour necrosis factor, LIGHT (also known as TNFSF14), interferon-γ, interleukin-13 (IL-13) and IL-17 can modify epithelial barrier function by mechanisms that include new protein synthesis, membrane trafficking, kinase activation, cytoskeletal modulation and epithelial apoptosis. The contributions of these events to acute and chronic barrier regulation are distinct and may complement one another.Increased intestinal permeability is associated with inflammatory bowel disease but can also be present in healthy individuals. Mouse models confirm that intestinal barrier dysregulation alone is insufficient to cause disease, but they also show that enhanced tight junction permeability can accelerate disease onset and increase severity.In addition to activating pro-inflammatory events, intestinal barrier dysfunction initiates immunoregulatory processes. Defects in these processes may be a cause of inflammatory disease.Further investigation of pathways that integrate mucosal barrier function, or dysfunction, and immune regulation will lead to a better understanding of the mechanisms underlying these complex interactions and provide a rational basis for the development of more effective and targeted therapeutic interventions.

Molecular regulation of the intestinal epithelial barrier: implication in human diseases.

The Effect of Intrinsic Factors and Mechanisms in Shaping Human Gut Microbiota

Critical Signaling Transduction Pathways and Intestinal Barrier: Implications for Pathophysiology and Therapeutics

Intestinal epithelial barrier dysfunction in disease and possible therapeutical interventions

Deciphering internal and external factors influencing intestinal junctional complexes

Intestinal barrier: Molecular pathways and modifiers

Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development

Research progress on intestinal mucosal barrier and probiotics

Surface components and metabolites of probiotics for regulation of intestinal epithelial barrier

Probiotics, Prebiotics and Epithelial Tight Junctions: A Promising Approach to Modulate Intestinal Barrier Function

Intestinal Barrier Impairment, Preservation, and Repair: An Update

Functions of Intestinal Epithelial Barriers Modulated by Probiotics and Mechanisms

Intestinal barrier function: Molecular regulation and disease pathogenesis

New Insights into Bacterial Mechanisms and Potential Intestinal Epithelial Cell Therapeutic Targets of Inflammatory Bowel Disease

Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease

Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases

The diet-microbiota axis: a key regulator of intestinal permeability in human health and disease

Gut Microbiota and Intestinal Trans-Epithelial Permeability

Intestinal mucosal barrier function in health and disease

Microbial Metabolite Regulation of Epithelial Cell-Cell Interactions and Barrier Function

Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases